Abstract:
The interval right before menopause is called the menopausal transition period, or perimenopause.
This physiological end of the regular menstrual cycle is often accompanied by a variety of
symptoms, including hot flashes, sleeplessness, dry vagina, memory loss, weariness, poor libido,
night sweats, and irritability. The most prevalent symptom among all of these is sleeplessness or
insomnolence. Numerous risk factors might induce insomnia, which subsequently deteriorates one's
quality of life.
In order to obtain data for identifying the risk variables contributing to insomnolence, this study was
planned as a scoping review. Four databases were searched, adhering to PRISMA rules, for articles
that described the risk factors of insomnolence that were published between 2013 and 2023. The
databases that are used are Scopus, MEDLINE, Google Scholar, and PubMed. The terms
perimenopause, insomnia, risk factors, insomnolence, sleep disturbances, and aetiology of sleep
disorders were the keywords that were utilized.
This review study illustrates the contributing elements to insomnolence in perimenopausal women
and the decline in quality of life that ensues. It also covers an array of non-pharmaceutical, non-
invasive therapeutic alternatives that are helpful in reducing insomnia symptoms.
